Total Payments
$9,665
2024 Payments
$40.66
Companies
44
Transactions
741
Medicare Patients
5,115
Medicare Billing
$463,355
Payment Breakdown by Category
Food & Beverage$9,352 (96.8%)
Education$313.53 (3.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $9,352 | 720 | 96.8% |
| Education | $313.53 | 21 | 3.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,010 | 81 | $0 (2021) |
| Novo Nordisk Inc | $853.73 | 69 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $761.00 | 52 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $719.09 | 59 | $0 (2021) |
| PFIZER INC. | $685.04 | 78 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $545.94 | 52 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $541.39 | 43 | $0 (2021) |
| Allergan, Inc. | $482.37 | 50 | $0 (2021) |
| Lilly USA, LLC | $394.37 | 30 | $0 (2024) |
| Astellas Pharma US Inc | $394.11 | 13 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $40.66 | 2 | Lilly USA, LLC ($22.66) |
| 2023 | $91.95 | 5 | ABBVIE INC. ($62.11) |
| 2022 | $229.89 | 8 | Boston Scientific Corporation ($129.10) |
| 2021 | $693.06 | 41 | GlaxoSmithKline, LLC. ($133.80) |
| 2020 | $2,567 | 182 | GlaxoSmithKline, LLC. ($275.56) |
| 2019 | $2,205 | 173 | GlaxoSmithKline, LLC. ($233.38) |
| 2018 | $1,417 | 116 | Novo Nordisk Inc ($210.88) |
| 2017 | $2,421 | 214 | Janssen Pharmaceuticals, Inc ($223.05) |
All Payment Transactions
741 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/27/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $18.00 | General |
| Category: Insomnia | ||||||
| 03/13/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Diabetes | ||||||
| 11/07/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: VACCINES | ||||||
| 06/01/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: VACCINES | ||||||
| 04/27/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: NEUROSCIENCE | ||||||
| 01/19/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2022 | Boston Scientific Corporation | General - Erectile Dysfunction (Device) | Food and Beverage | In-kind items and services | $129.10 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 12/08/2022 | Lilly USA, LLC | — | Education | In-kind items and services | $11.71 | General |
| 10/18/2022 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: VACCINES | ||||||
| 09/21/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: NEUROSCIENCE | ||||||
| 08/04/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $11.88 | General |
| Category: NEUROSCIENCE | ||||||
| 07/26/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $12.11 | General |
| Category: NEUROSCIENCE | ||||||
| 06/07/2022 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, PAXLOVID | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: VACCINES | ||||||
| 01/12/2022 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/23/2021 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $13.56 | General |
| Category: VACCINES | ||||||
| 10/12/2021 | PFIZER INC. | PREVNAR 13 (Biological), PREVNAR 20 | Food and Beverage | In-kind items and services | $15.10 | General |
| Category: VACCINES | ||||||
| 03/25/2021 | GlaxoSmithKline, LLC. | ANORO ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $1.06 | General |
| Category: RESPIRATORY | ||||||
| 03/24/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: NEUROSCIENCE | ||||||
| 03/24/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: Cardiovascular | ||||||
| 03/24/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: Diabetes | ||||||
| 03/22/2021 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $26.82 | General |
| Category: RESPIRATORY | ||||||
| 03/22/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: RESPIRATORY | ||||||
| 03/18/2021 | AbbVie Inc. | CREON (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/17/2021 | Teva Pharmaceuticals USA, Inc. | AirDuo Digihaler (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,181 | 1,582 | $246,827 | $123,521 |
| 2022 | 12 | 1,243 | 1,749 | $251,944 | $123,914 |
| 2021 | 13 | 1,228 | 1,809 | $223,223 | $108,512 |
| 2020 | 15 | 1,463 | 2,456 | $252,895 | $107,409 |
Total Patients
5,115
Total Services
7,596
Medicare Billing
$463,355
Procedure Codes
54
All Medicare Procedures & Services
54 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 305 | 615 | $121,155 | $50,378 | 41.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 201 | 201 | $39,597 | $25,074 | 63.3% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 158 | 160 | $13,280 | $11,420 | 86.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 38 | 38 | $17,290 | $10,409 | 60.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 115 | 152 | $20,216 | $9,040 | 44.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 165 | 167 | $6,680 | $4,889 | 73.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 37 | 44 | $11,704 | $4,690 | 40.1% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 12 | 12 | $3,480 | $1,894 | 54.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 24 | 24 | $7,248 | $1,856 | 25.6% |
| 91320 | Sarscv2 vac 30mcg trs-suc im | Office | 2023 | 12 | 12 | $1,656 | $1,413 | 85.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 38 | 38 | $1,520 | $1,090 | 71.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 36 | 77 | $847.00 | $646.80 | 76.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 12 | 12 | $804.00 | $431.97 | 53.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 28 | 30 | $1,350 | $289.64 | 21.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 312 | 678 | $133,566 | $52,849 | 39.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 225 | 225 | $44,325 | $28,245 | 63.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 175 | 184 | $14,828 | $12,558 | 84.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 101 | 145 | $19,285 | $8,838 | 45.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 52 | 56 | $14,896 | $6,516 | 43.7% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 20 | 20 | $8,882 | $5,535 | 62.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 183 | 193 | $7,720 | $5,470 | 70.9% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 11 | 11 | $1,419 | $1,414 | 99.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 33 | 33 | $1,320 | $941.98 | 71.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 52 | 65 | $2,925 | $640.41 | 21.9% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 13 | 13 | $1,392 | $532.59 | 38.3% |
About Dr. Thomas Kurland, DO
Dr. Thomas Kurland, DO is a Internal Medicine healthcare provider based in York, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1679549901.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Kurland, DO has received a total of $9,665 in payments from pharmaceutical and medical device companies, with $40.66 received in 2024. These payments were reported across 741 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($9,352).
As a Medicare-enrolled provider, Kurland has provided services to 5,115 Medicare beneficiaries, totaling 7,596 services with total Medicare billing of $463,355. Data is available for 4 years (2020–2023), covering 54 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location York, PA
- Active Since 02/27/2006
- Last Updated 03/04/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1679549901
Products in Payments
- FARXIGA (Drug) $508.55
- JARDIANCE (Drug) $410.63
- XARELTO (Drug) $374.36
- Vascepa (Drug) $345.27
- Ozempic (Drug) $344.69
- TRELEGY ELLIPTA (Drug) $327.10
- CHANTIX (Drug) $304.93
- XIFAXAN (Drug) $286.44
- TOUJEO (Drug) $275.87
- ENTRESTO (Drug) $235.39
- ANORO ELLIPTA (Drug) $210.12
- Aimovig (Biological) $200.73
- ANORO (Drug) $199.72
- TRULICITY (Drug) $177.79
- INVOKANA (Drug) $165.56
- Saxenda (Drug) $152.93
- Tresiba (Drug) $145.65
- MYRBETRIQ (Drug) $135.08
- VRAYLAR (Drug) $134.80
- Prolia (Biological) $129.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in York
Nader Zaki, M.d, M.D
Internal Medicine — Payments: $420,610
Internal Medicine $420,610
Dr. Christopher Wenger, D.o, D.O
Internal Medicine — Payments: $262,050
Internal Medicine $262,050
Dr. Rodger Stitt, M.d, M.D
Internal Medicine — Payments: $14,593
Internal Medicine $14,593
Ivan Marchena- Mendez, M.d, M.D
Internal Medicine — Payments: $12,136
Internal Medicine $12,136
Dr. Nishi Patel, M.d, M.D
Internal Medicine — Payments: $11,501
Internal Medicine $11,501
Dr. Peter Kouvatsos, Do, DO
Internal Medicine — Payments: $10,090
Internal Medicine $10,090